ACT Genomics Overview
- Year Founded
-
2013
- Status
-
Acquired/Merged
- Employees
-
117
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$20M
ACT Genomics General Information
Description
Provider of cancer molecular information services designed to rewrite the existing model of diagnostic, treatment, and monitoring. The company's cancer molecular information services implement next-generation sequencing and multiplex molecular testing, coupled with bioinformatics tools, curated proprietary databases and data visualization technologies, enabling oncologists to address the key challenges in cancer treatments.
Contact Information
Website
www.actgenomics.com(Operating Subsidiary)
Corporate Office
- 3F., Number 345, Xinhu 2nd Rd.
- Neihu District
- Taipei, 114
- Taiwan
Corporate Office
- 3F., Number 345, Xinhu 2nd Rd.
- Neihu District
- Taipei, 114
- Taiwan
ACT Genomics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 30-Dec-2022 | $20M | Completed | Profitable | ||
| 4. Later Stage VC (Series D) | 01-Jan-2021 | Completed | Profitable | |||
| 3. Early Stage VC | 26-Sep-2018 | Completed | Startup | |||
| 2. Early Stage VC (Series B) | 01-May-2016 | $12.5M | $20.5M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 13-Feb-2015 | $8M | $8M | Completed | Startup |
ACT Genomics Comparisons
Industry
Financing
Details
ACT Genomics Competitors (26)
One of ACT Genomics’s 26 competitors is Oncologica, a Corporation company based in Cambridge, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Oncologica | Corporation | Cambridge, United Kingdom | ||||
| Ambry Genetics | Formerly PE-Backed | Aliso Viejo, CA | ||||
| Datar Cancer Genetics | Venture Capital-Backed | Nashik, India | ||||
| BGI Genomics | Formerly VC-backed | Shenzhen, China | ||||
| Genuity Science | Formerly VC-backed | Dublin, Ireland |
ACT Genomics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
ACT Genomics Patents
ACT Genomics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20190385701-A1 | Method and system for sequence alignment and variant calling | Active | 29-Dec-2017 | ||
| US-10854317-B2 | Method and system for sequence alignment and variant calling | Active | 29-Dec-2017 |
ACT Genomics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
ACT Genomics Former Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Aflac Ventures | Corporate Venture Capital | Minority | ||
| CDIB Capital International | PE/Buyout | Minority | ||
| CLSA Capital Partners | Asset Manager | Minority | ||
| Drive Catalyst | Corporate Venture Capital | Minority | ||
| Eminent Venture Capital | Venture Capital | Minority |
ACT Genomics Investments & Acquisitions (3)
ACT Genomics’s most recent deal was a Joint Venture with Joint Venture (Cerba Research / ACT Genomics). The deal was made on 24-Aug-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Joint Venture (Cerba Research / ACT Genomics) | 24-Aug-2021 | Joint Venture | Laboratory Services (Healthcare) | ||
| MC Diagnostics | 06-Jul-2021 | Merger/Acquisition | Biotechnology | ||
| ACTmed | 01-Apr-2017 | Joint Venture | Drug Discovery |
ACT Genomics Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Sanomics | Hong Kong, Hong Kong | 2015 | |
| MC Diagnostics | Bromborough, United Kingdom | 2006 |
ACT Genomics FAQs
-
When was ACT Genomics founded?
ACT Genomics was founded in 2013.
-
Where is ACT Genomics headquartered?
ACT Genomics is headquartered in Taipei, Taiwan.
-
What is the size of ACT Genomics?
ACT Genomics has 117 total employees.
-
What industry is ACT Genomics in?
ACT Genomics’s primary industry is Biotechnology.
-
Is ACT Genomics a private or public company?
ACT Genomics is a Private company.
-
What is the current valuation of ACT Genomics?
The current valuation of ACT Genomics is .
-
What is ACT Genomics’s current revenue?
The current revenue for ACT Genomics is .
-
How much funding has ACT Genomics raised over time?
ACT Genomics has raised $50M.
-
Who are ACT Genomics’s investors?
Aflac Ventures, CDIB Capital International, CLSA Capital Partners, Drive Catalyst, and Eminent Venture Capital are 5 of 13 investors who have invested in ACT Genomics.
-
Who are ACT Genomics’s competitors?
Oncologica, Ambry Genetics, Datar Cancer Genetics, BGI Genomics, and Genuity Science are some of the 26 competitors of ACT Genomics.
-
When was ACT Genomics acquired?
ACT Genomics was acquired on 30-Dec-2022.
-
Who acquired ACT Genomics?
ACT Genomics was acquired by Prenetics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
